Andrew M Schwartz1, Kevin X Farley2, George N Guild1, Thomas L Bradbury1. 1. Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, GA; Department of Orthopaedic Surgery, Emory University Orthopaedics & Spine Hospital, Tucker, GA. 2. Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, GA.
Abstract
BACKGROUND: As the incidence of primary total joint arthroplasty rises in the United States, it is important to investigate how this will impact rates of revision arthroplasty. The purpose of this study was to analyze the incidence and future projections of revision total hip arthroplasty (rTHA) and revision total knee arthroplasty (rTKA) to 2030. Anticipating surgical volume will aid surgeons in designing protocols to efficiently and effectively perform rTHA/rTKA. METHODS: The national inpatient sample was queried from 2002 to 2014 for all rTHA/rTKA. Using previously validated measures, Poisson and linear regression analyses were performed to project annual incidence of rTHA/rTKA to 2030, with subgroup analyses on modes of failure and age. RESULTS: In 2014, there were 50,220 rTHAs and 72,100 rTKAs. From 2014 to 2030, rTHA incidence is projected to increase by between 43% and 70%, whereas rTKA incidence is projected to increase by between 78% and 182%. The 55-64 and 65-74 age groups increased in revision incidence during the study period, whereas 75-84 age group decreased in incidence. For rTKA, infection and aseptic loosening are the 2 most common modes of failure, whereas periprosthetic fracture and infection are most common for rTHA. CONCLUSION: The incidence of rTHA/rTKA is projected to increase, particularly in young patients and for infection. Given the known risk factor profiles and advanced costs associated with revision arthroplasty, our projections should encourage institutions to generate revision-specific protocols to promote safe pathways for cost-effective care that is commensurate with current value-based health care trends. LEVEL OF EVIDENCE: IV.
BACKGROUND: As the incidence of primary total joint arthroplasty rises in the United States, it is important to investigate how this will impact rates of revision arthroplasty. The purpose of this study was to analyze the incidence and future projections of revision total hip arthroplasty (rTHA) and revision total knee arthroplasty (rTKA) to 2030. Anticipating surgical volume will aid surgeons in designing protocols to efficiently and effectively perform rTHA/rTKA. METHODS: The national inpatient sample was queried from 2002 to 2014 for all rTHA/rTKA. Using previously validated measures, Poisson and linear regression analyses were performed to project annual incidence of rTHA/rTKA to 2030, with subgroup analyses on modes of failure and age. RESULTS: In 2014, there were 50,220 rTHAs and 72,100 rTKAs. From 2014 to 2030, rTHA incidence is projected to increase by between 43% and 70%, whereas rTKA incidence is projected to increase by between 78% and 182%. The 55-64 and 65-74 age groups increased in revision incidence during the study period, whereas 75-84 age group decreased in incidence. For rTKA, infection and aseptic loosening are the 2 most common modes of failure, whereas periprosthetic fracture and infection are most common for rTHA. CONCLUSION: The incidence of rTHA/rTKA is projected to increase, particularly in young patients and for infection. Given the known risk factor profiles and advanced costs associated with revision arthroplasty, our projections should encourage institutions to generate revision-specific protocols to promote safe pathways for cost-effective care that is commensurate with current value-based health care trends. LEVEL OF EVIDENCE: IV.
Authors: Hilal Maradit Kremers; Laura W Lewallen; Tad M Mabry; Daniel J Berry; Elie F Berbari; Douglas R Osmon Journal: J Arthroplasty Date: 2014-10-15 Impact factor: 4.757
Authors: Steven M Kurtz; Edmund C Lau; Kevin L Ong; Edward M Adler; Frank R Kolisek; Michael T Manley Journal: Clin Orthop Relat Res Date: 2017-12 Impact factor: 4.176
Authors: Chuan Kong Koh; Irene Zeng; Saiprassad Ravi; Mark Zhu; Kelly G Vince; Simon W Young Journal: Clin Orthop Relat Res Date: 2017-06-01 Impact factor: 4.176
Authors: Bheeshma Ravi; Ruth Croxford; William M Reichmann; Elena Losina; Jeffrey N Katz; Gillian A Hawker Journal: Best Pract Res Clin Rheumatol Date: 2012-10 Impact factor: 4.098
Authors: Timothy L Tan; Michael M Kheir; Dean D Tan; Edward J Filippone; Eric H Tischler; Antonia F Chen Journal: J Arthroplasty Date: 2016-03-17 Impact factor: 4.757
Authors: Edward Burn; Christopher J Edwards; David W Murray; Alan Silman; Cyrus Cooper; Nigel K Arden; Rafael Pinedo-Villanueva; Daniel Prieto-Alhambra Journal: BMJ Open Date: 2018-01-27 Impact factor: 2.692
Authors: Gary Tran; Lafi S Khalil; Allen Wrubel; Chad L Klochko; Jason J Davis; Steven B Soliman Journal: Skeletal Radiol Date: 2020-11-03 Impact factor: 2.199
Authors: Claudio Glowalla; Max Ertl; Ulrich Lenze; Igor Lazic; Rainer Burgkart; Jan J Lang; Rudiger VON Eisenhart-Rothe; Florian Pohlig Journal: In Vivo Date: 2022 Mar-Apr Impact factor: 2.155
Authors: Richard N de Steiger; Peter L Lewis; Ian Harris; Michelle F Lorimer; Stephen E Graves Journal: Clin Orthop Relat Res Date: 2022-08-18 Impact factor: 4.755
Authors: Qi Gao; Claire Rhee; Masahiro Maruyama; Zhong Li; Huaishuang Shen; Ning Zhang; Takeshi Utsunomiya; Elijah Ejun Huang; Zhenyu Yao; Bruce A Bunnell; Hang Lin; Rocky S Tuan; Stuart B Goodman Journal: Biomedicines Date: 2021-05-01